Health Care·Health Care Equipment·$92.3B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.31 | N/A | -0.31% |
management commentary, guidance changes, and full analysis available with Pro.
| -0.31% |
Tone: Defensive
Management expressed concerns about current market conditions impacting performance. They highlighted efforts to improve efficiency but did not provide detailed future plans.
Management noted ongoing challenges in the market.
They emphasized a focus on operational efficiency.
Future growth strategies were discussed but lacked specifics.
The earnings report indicates that Boston Scientific faced challenges that impacted its earnings per share, resulting in a stock decline of 2.67%. Investors may be concerned about the lack of guidance and management's cautious tone regarding market conditions. This could lead to increased scrutiny in the coming quarters as the company navigates these challenges.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
HARTFORD INS GROUP I
Oct 23, 2017